Current Dutch Practice on Caesarean Sections: Identification of Barriers and Facilitators for Optimal Care (SIMPLE)

October 29, 2012 updated by: Maastricht University Medical Center

Current Dutch Practice on Caesarean Sections: Identification of Barriers and Facilitators for Optimal Care.

Caesarean (CS) delivery rates in the Netherlands increased from 5 to 15% the last 20 years. CSs have no clear benefit for overall neonatal outcome and are associated with higher maternal complications and high costs. Dutch guidelines offer clear recommendations on factors that have a direct effect on the decision to perform a CS.

Hypothesis: there is incomplete adherence to the recommendations from the guidelines on CS among Dutch gynaecologists.

This study consists of four phases:

  1. Development of quality indicators: A set of quality indicators regarding the process, structure and outcome of care will be developed according to the RAND-modified Delphi method. A representative, national expert panel consisting of 12 to 15 obstetricians and midwives will participate.
  2. Current care study: The current Dutch care will be studied in 20 hospitals (N=80 gynaecologists). 1000 files on performed CSs are analyzed regarding the adherence to the developed quality indicators. To get insight into Dutch practices compared to international data, basic obstetrical data will be extracted from the delivery database.
  3. Barrier analysis: A barrier analysis will be carried out based on the results of the current care study. Two groups of hospitals will be identified in the upper and lower extremes of the 'adherence distribution': 5 hospitals with the lowest and 5 hospitals with the highest adherence scores. Factors that determine the decision to perform a CS or not (barriers and facilitators) will be analyzed in both groups using semi-structured interviews among 15-20 professionals and 15-20 patients. A questionnaire will be used to study the 'prevalence' of these factors among all obstetric gynaecologists in the Netherlands and among 200 patients.
  4. Controlled before- and-after (CBA) study: Based on the outcomes of the current care study and the barrier analysis, a tailor made implementation strategy will be developed in order to increase adherence to the CS quality indicators. Target groups will be selected with focus on women with both a high incidence of the indicator and low indicator adherence. The strategy will be executed and evaluated in a CBA-study in 12 hospitals (6 intervention, 6 control) in terms of effectiveness, experiences and costs. The sample size will be dependent on the target group and adherence to the quality indicators regarding this target group. These data will be available after performing the current care and the barrier study.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Almelo, Netherlands
        • Ziekenhuisgroep Twente
      • Almere, Netherlands
        • Flevo ziekenhuis
      • Amersfoort, Netherlands
        • Meander Medisch Centrum
      • Amsterdam, Netherlands
        • Academisch Medisch Centrum
      • Apeldoorn, Netherlands
        • Gelreziekenhuizen
      • Arnhem, Netherlands
        • Rijnstate Ziekenhuis
      • Capelle aan den Ijjsel, Netherlands
        • IJsselland ziekenhuis
      • Eindhoven, Netherlands
        • Catharina-ziekenhuis
      • Groningen, Netherlands
        • University Medical Centre Groningen
      • Hardenberg, Netherlands
        • Ropcke-Zweers Ziekenhuis
      • Heerlen, Netherlands
        • Atrium Medisch Centrum Parkstad
      • Helmond, Netherlands
        • Elkerliek Ziekenhuis
      • Hilversum, Netherlands
        • Tergooiziekenhuizen
      • Maastricht, Netherlands
        • Maastricht Universitair Medisch Centrum
      • Nijmegen, Netherlands
        • Universitair Medisch Centrum St. Radboud
      • Sittard, Netherlands
        • Orbis Medisch Centrum
      • Utrecht, Netherlands
        • Universitair Medisch Centrum Utrecht
      • Veldhoven, Netherlands
        • Máxima Medisch Centrum
      • Weert, Netherlands
        • Sint Jansgasthuis
      • Zaandam, Netherlands
        • Zaans Medisch Centrum

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

  1. Development of quality indicators: 12-15 obstetricians and midwives
  2. Current care study: All women (1000) who underwent a CS in one of the 20 participating hospitals during the study period (3-4 months). All hospitals participate in the Dutch consortium and consist of university teaching-, non-university teaching- and non-university-non-teaching hospitals.
  3. Barrier analysis: Qualitative: 15-20 professionals and 15-20 patients from the hospitals in the upper and lower extremes of the 'adherence distribution'. Quantitative: obstetricians in the Netherlands and 200 experienced patients.
  4. CBA study: depending on the outcome of phase 2 and 3 of the study, the implementation strategy will be designed for a target group with low guideline adherence and high incidence.

Description

Inclusion Criteria:

  • A previous caesarean section in a 3-4 month time period.

Exclusion Criteria:

  • Major congenital malformality
  • Fetal death prior to onset of delivery
  • Duration of pregnancy less than 24 weeks of gestation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Caesarean section
An implementation strategy to improve outcome for women in labour will be developed depending on the outcome of the current care study and the barrier and facilitator analysis.The strategy will be executed and evaluated in a controlled before-and-after study in 12 hospitals (6 intervention, 6 control)
Vaginal birth (control)
An implementation strategy to improve outcome for women in labour will be developed depending on the outcome of the current care study and the barrier and facilitator analysis.The strategy will be executed and evaluated in a controlled before-and-after study in 12 hospitals (6 intervention, 6 control)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
1) Development of quality indicators: development of a valid set of quality indicators for measuring current Dutch care on caesarean sections
Time Frame: December 2010 - October 2013
December 2010 - October 2013
2) Current care study: The main outcome is the adherence to the quality indicators regarding the process, structure and outcome (maternal and fetal) of care
Time Frame: December 2010 - October 2013
December 2010 - October 2013
3) Barrier and facilitator analysis: Identification of barriers and facilitators to perform a caesarean section
Time Frame: December 2010 - October 2013
December 2010 - October 2013
4) Controlled before-and-after study: effectiveness of the implementation strategy defined as observed increase in adherence between the intervention and control hospitals and actual CS rates in both groups
Time Frame: December 2010 - October 2013
December 2010 - October 2013

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
1) Development of quality indicators: no secondary outcomes
Time Frame: December 2010 - October 2013
December 2010 - October 2013
2) Current care study: International comparison
Time Frame: December 2010- October 2013
Dutch practice as compared to international data (Robson criteria)
December 2010- October 2013
3) Barrier and facilitator analysis: no secondary outcomes
Time Frame: December 2010-October 2013
December 2010-October 2013
4) Controlled before-and-after study: experiences and satisfaction of health care providers and patients with the implementation strategy and applicability and costs of the strategy
Time Frame: December 2010-October 2013
December 2010-October 2013

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hubertina CJ Scheepers, Ph.D., Maastricht University Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2010

Primary Completion (Anticipated)

October 1, 2013

Study Registration Dates

First Submitted

December 15, 2010

First Submitted That Met QC Criteria

December 15, 2010

First Posted (Estimate)

December 16, 2010

Study Record Updates

Last Update Posted (Estimate)

October 30, 2012

Last Update Submitted That Met QC Criteria

October 29, 2012

Last Verified

October 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • 09-4-047
  • 17100.3006 (Other Grant/Funding Number: zonMW)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caesarean Section

Clinical Trials on Implementation aids

3
Subscribe